Gabapentin Market
- 2026 年市場規模
- USD 3.9 Bn
- 2033 年預估規模
- USD 5.8 Bn
- 年複合成長率 CAGR
- 5.8%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Gabapentin Market, By Dosage Form (Capsules, Tablets, Oral Solutions, and Others), By Application (Neuropathic Pain, Epilepsy, Restless Legs Syndrome (RLS), and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
報告摘要
The global gabapentin market is estimated to be valued at USD 3.9 Bn in 2026 and is expected to reach USD 5.8 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033. The global gabapentin market is a substantial part of the global neurological and pain management pharmaceuticals market. The market includes branded and generic formulations of this gamma-aminobutyric acid (GABA) analog agent. Emerging as an anticonvulsant used to treat epilepsy, the marketed drug now has many off-label uses to treat nerve-related pain, restless leg syndrome, various neurological disorders, anxiety, fibromyalgia, and other disorders. Market growth is predicted to accelerate with more recognized uses.
Competitive dynamics in the market stem from the aggressive pricing practices, product portfolios, and global presence of large pharmaceutical companies and generic manufacturers. The market is tightly regulated with a strict process of approval combined with post-marketing surveillance in eye of fear of abuse potential and off-label use. Market segmentation features immediate release and extended-release stages, various strengths, and a wide number of indications and distribution channels including hospital, retail, and online pharmacy in developed and emerging markets.
Market Dynamics
The global gabapentin market is driven by soaring incidence of neurological and chronic pain conditions with many countries witnessing sharp ascent in the incidence of epilepsy and various forms of neuropathic pains beckoning the need for more effective treatments. The aging population and the high incidence of elderly suffering from diabetic neuropathy and post-herpetic neuralgias are also contributing to the growth of certain specific markets. Furthermore, the off-label uses of gabapentin in anxiety disorder, bipolar disorder and sleep disorder is also helping to propel the growth of various markets. Increasing recognition of the role of drugs in pain management is further fueling the growth of these markets.
However, a number of constraints are present in the market, such as generic competition becoming intense after patents expire, resulting in pricing pressure on, and lower profit margins for, branded products. Negative regulatory reviews in relation to misuse potential, dependent risk and side effect liability including dizziness and cognitive deterioration is also a hindrance. However, there are a number of opportunities for the market, such as increasing opportunities for use in emerging markets, aided by improving healthcare infrastructure and increasing healthcare expenditure, and the invention of new formulations, such as extended-release formulations and combination products, and investigations into new therapeutic uses.
Key Features of the Study
• This report provides in-depth analysis of the global gabapentin market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global gabapentin market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin Limited, Amneal Pharmaceuticals, Zydus Lifesciences, Viatris Inc., Apotex Inc., and Dr. Reddy's Laboratories
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global gabapentin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gabapentin market
Market Segmentation
• Dosage Form Insights (Revenue, USD Bn, 2021 - 2033)
o Capsules
o Tablets
o Oral Solutions
o Others
• Application Insights (Revenue, USD Bn, 2021 - 2033)
o Neuropathic Pain
o Epilepsy
o Restless Legs Syndrome (RLS)
o Others
• Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o Pfizer Inc.
o Teva Pharmaceutical Industries Ltd.
o Sun Pharmaceutical Industries Ltd.
o Aurobindo Pharma
o Lupin Limited
o Amneal Pharmaceuticals
o Zydus Lifesciences
o Viatris Inc.
o Apotex Inc.
o Reddy's Laboratories
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Global Gabapentin Market, By Dosage Form
Global Gabapentin Market, By Application
Global Gabapentin Market, By Distribution Channel
Global Gabapentin Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Regulatory Scenario
o Key Developments
o Industry Trends
4. Global Gabapentin Market, By Dosage Form, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Capsules
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Tablets
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Oral Solutions
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Gabapentin Market, By Application, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Neuropathic Pain
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Epilepsy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Restless Legs Syndrome (RLS)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Gabapentin Market, By Distribution Channel, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Gabapentin Market, By Region, 2021 - 2033, Value (USD Bn)
o Introduction
Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
Regional Trends
o North America
Introduction
Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
o South Africa
o North Africa
o Central Africa
8. Competitive Landscape
o Pfizer Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Teva Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Sun Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Aurobindo Pharma
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Lupin Limited
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Amneal Pharmaceuticals
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Zydus Lifesciences
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Viatris Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Apotex Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Reddy's Laboratories
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
9. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
10. References and Research Methodology
o References
o Research Methodology
o About us
*Browse 32 market data tables and 28 figures on ‘Gabapentin Market' - Global forecast to 2033
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們